Christine Ann Fox Mereo Biopharma Group PLC (MREO) insider trading activity
Christine Ann Fox is Chief Financial Officer of Mereo Biopharma Group plc. Currently has a direct ownership of 89,285 shares of MREO, which is worth approximately $262,497. The most recent transaction as insider was on Sep 13, 2024, when has been sold 19,158 shares (American Depositary Shares representing Ordinary Shares) at a price of $4.22 per share, resulting in proceeds of $80,846. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
89.3K
0%
3M change
n/a
12M change
Total Value Held
$262,497
Christine Ann Fox Transaction History
CAF
Christine Ann Fox
Chief Financial Officer
London, X0